GENE ONLINE|News &
Opinion
Blog

2026-02-04|

Correction Issued on February 4, 2026, Regarding ePlus Inc. Stock News

by GOAI
Share To

On February 4, 2026, a correction was issued regarding previously released information about ePlus Inc., a technology solutions provider. The update clarified details related to the company’s stock news and addressed inaccuracies in prior reports.

The correction was published at 9:10 PM GMT and made available through an online source. It provided revised information to ensure accuracy for stakeholders and investors following developments related to ePlus Inc. No further details were disclosed in the announcement regarding the nature of the corrections or specific changes made to earlier statements.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 4, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Sands China Partners with Alipay and Macau Pass to Expand Cashless Payment Systems in Macau
2026-02-11
Society Pass Incorporated Prices Public Offering at $3.00 Per Share to Raise $3 Million
2026-02-11
Beach Cities Commercial Bank Reports $12.4 Million Q4 Net Income with $2.1 Billion in Total Assets
2026-02-11
Icahn Enterprises to Discuss Fourth Quarter 2025 Financial Results in February 2026 Conference Call
2026-02-11
Study Links Long-Term Pollutant Exposure to Immune Evasion in Early Lung Lesions
2026-02-11
Global Study Links Physical Inactivity to Severe Complications in 2.3 Million Adults with Type 2 Diabetes
2026-02-11
NorthWestern Energy Reports $1.4 Billion Revenue and $150 Million Net Income for 2025
2026-02-11
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-23
BIO Europe Spring (Biotech Partnering)
Lisbon, Portugal
Scroll to Top